Various provinces and cities have introduced support programs, and the biomedical industry will become a new market opportunity

[pharmaceutical network industry trends] recently, nine ministries and commissions, including Shanghai Health and Health Commission, Shanghai development and Reform Commission and Shanghai Science and Technology Commission, jointly issued the notice on the implementation plan of strengthening clinical research in Shanghai Medical and health institutions to support the development of biomedical industry We will further promote the development of the biomedical industry by encouraging clinicians, public health doctors and pharmacists to participate in clinical research and incorporating the performance of clinical research into the application and assessment of senior professional titles Photo source: pharmaceutical.com in fact, the global biomedical industry is currently in the window period of explosive growth, and countries around the world are accelerating the biotechnology revolution and industrial change, seizing the commanding height of the development of biomedical industry The pharmaceutical industry in China is in the new stage of innovation and transformation, and will not let this industry pass In addition to Shanghai, many provinces and cities have introduced policies to support the biomedical industry to encourage innovation and high-quality development Hebei On November 28, the Information Office of the people's Government of Hebei Province held a press conference and released several policies on supporting the high-quality development of the biomedical industry (hereinafter referred to as "policies") The policies put forward in four aspects: breaking the bottleneck constraints of industrial development, strengthening the research and development of new drugs and technological innovation, supporting enterprises to become stronger and better, and optimizing the industrial development ecology 6 policy measures In particular, in terms of solving the bottleneck constraints of industrial development, the policy proposes that priority should be given to solving the land for project construction, and for major biomedical projects in the fields of high-end medical devices, stem cells and regenerative medicine, priority should be given to meeting the land use indicators and the balance of occupation and compensation indicators Guarantee the supply of production factors of biomedical enterprises, and include them in the scope of supply guarantee of natural gas, electric power, transportation and other production factors In addition, Hebei will vigorously introduce leading enterprises Leading enterprises should be encouraged to promote the whole business link development of digital research and development, production, management and operation, and organize and implement a number of Internet plus application demonstration projects, such as digital workshop and intelligent manufacturing Tianjin Previously, the author learned from the press conference of "supporting the high-quality development and reform measures of biomedical industry" held by Tianjin municipal market supervision committee, Tianjin pharmaceutical regulatory bureau and Tianjin intellectual property office that Tianjin released "several opinions on further supporting the high-quality development of biomedical industry in Tianjin" (hereinafter referred to as "opinions") to the public and announced to the public New policies and measures of the market supervision committee to assist the development of key advantageous industries in the city It is reported that 10 types of support policies have been proposed Among them, in terms of encouraging biomedical enterprises to improve their patent comprehensive ability, Tianjin will grant subsidies according to different standards for inventions that have obtained domestic and foreign invention patents and foreign authorizations, and implement patent related fee reduction Chongqing recently issued the guiding opinions on accelerating the development of biomedical industry (hereinafter referred to as the opinions), proposing to develop the biomedical industry by increasing the selection of varieties, improving the manufacturing capacity, making up the short board of the platform, optimizing the industrial layout and other measures, with a total output value of 130 billion yuan by 2022 Among them, the opinions put forward six measures to promote the development of biomedical industry, including increasing R & D innovation, promoting the construction of key platforms in the industrial chain, supporting with artificial intelligence and big data, building biomedical industry cluster, strengthening the talent base and increasing investment attraction Next, our city will successively issue special policies to support the development of biomedical industry, give rewards and subsidies to enterprises in stages of new product research and development, industrial transformation, and implement more effective incentive measures for biomedical industry cluster.